Top Markets
Coin of the day
Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE
Rang in Aktien #4732
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Aktienkurs
$48.46
Marktkapitalisierung
$3.35B
Veränderung (1 Tag)
-1.09%
Veränderung (1 Jahr)
186.60%
Land
US
Handel Pulse Biosciences, Inc. (PLSE)

Kategorie

Aktien-Split-Historie für Pulse Biosciences, Inc. (PLSE)
Die Aktie Pulse Biosciences, Inc. (Symbol: PLSE) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 27, 2026 statt.
Eine PLSE-Aktie, die vor dem Aug 27, 2026 gekauft wurde, entspricht heute 0 PLSE-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH